- Home
- AENT vs SGHT Comparison
AENT vs SGHT Comparison
Compare AENT & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AENT
- SGHT
- Stock Information
- Founded
- AENT 1990
- SGHT 2011
- Country
- AENT United States
- SGHT United States
- Employees
- AENT N/A
- SGHT N/A
- Industry
- AENT Durable Goods
- SGHT Medical Specialities
- Sector
- AENT Consumer Discretionary
- SGHT Health Care
- Exchange
- AENT Nasdaq
- SGHT Nasdaq
- Market Cap
- AENT 161.5M
- SGHT 179.7M
- IPO Year
- AENT N/A
- SGHT 2021
- Fundamental
- Price
- AENT $4.97
- SGHT $3.45
- Analyst Decision
- AENT Strong Buy
- SGHT Buy
- Analyst Count
- AENT 1
- SGHT 8
- Target Price
- AENT $10.00
- SGHT $3.87
- AVG Volume (30 Days)
- AENT 42.0K
- SGHT 110.8K
- Earning Date
- AENT 09-18-2025
- SGHT 08-07-2025
- Dividend Yield
- AENT N/A
- SGHT N/A
- EPS Growth
- AENT N/A
- SGHT N/A
- EPS
- AENT 0.23
- SGHT N/A
- Revenue
- AENT $1,072,641,000.00
- SGHT $78,109,000.00
- Revenue This Year
- AENT N/A
- SGHT N/A
- Revenue Next Year
- AENT $0.73
- SGHT $11.22
- P/E Ratio
- AENT $21.40
- SGHT N/A
- Revenue Growth
- AENT N/A
- SGHT N/A
- 52 Week Low
- AENT $1.10
- SGHT $2.03
- 52 Week High
- AENT $11.57
- SGHT $8.28
- Technical
- Relative Strength Index (RSI)
- AENT 48.82
- SGHT 43.79
- Support Level
- AENT $5.57
- SGHT $3.41
- Resistance Level
- AENT $5.70
- SGHT $3.63
- Average True Range (ATR)
- AENT 0.59
- SGHT 0.19
- MACD
- AENT -0.15
- SGHT -0.01
- Stochastic Oscillator
- AENT 11.56
- SGHT 23.91
About AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.